Recombinant avian adeno-associated virus: Transgene expression in vivo and enhancement of expression in vitro

Avian Diseases

Volumn 50, Issue 2, 2006, Pages 216-221

  Estevez, Carlos ^a   Villegas, Pedro ^a  

^a UNIVERSITY OF GEORGIA   (United States)

Author keywords

Avian adeno associated virus; Genomic integration; Recombinant virus; Transgene expression

Indexed keywords

BETA GALACTOSIDASE;

ADENO ASSOCIATED VIRUS; ANIMAL; ARTICLE; CELL LINE; CHICK EMBRYO; CHICKEN; GENE EXPRESSION; GENETICS; HUMAN; LACTOSE OPERON; METABOLISM; TRANSGENE; TRANSGENIC ORGANISM; VIROLOGY;

ANIMALS; BETA-GALACTOSIDASE; CELL LINE; CHICK EMBRYO; CHICKENS; DEPENDOVIRUS; GENE EXPRESSION; HUMANS; LAC OPERON; ORGANISMS, GENETICALLY MODIFIED; TRANSGENES;

ADENO-ASSOCIATED VIRUS; AVIAN ADENO-ASSOCIATED VIRUS;

EID: 33746047520     PISSN: 00052086     EISSN: None     Source Type: Journal    
DOI: 10.1637/7174-030104R.1     Document Type: Article

References (20)

1. Estevez, C., and P. Villegas. Sequence analysis, viral rescue from infectious clones and generation of recombinant virions of the avian adeno-associated virus. Virus Res. 105:195-208. 2004.
2. Hsiao, C. D., F. J. Hsieh, and H. J. Tsai. Enhanced expression and stable transmission of transgenes flanked by inverted terminal repeats from adeno-associated virus in zebrafish. Dev. Dyn. 220:323-336. 2001.
3. Kearns, W. G., S. A. Afione, S. B. Fulmer, M. C. Pang, D. Erikson, M. Egan, M. J. Landrum, T. R. Flotte, and G. R. Cutting. Recombinant adeno-associated virus (AAV-CFTR) vectors do not integrate in a site-specific fashion in an immortalized epithelial cell line. Gene Ther. 3:748-755. 1996.
4. Muzyczka, N. Adeno-associated virus (AAV) vectors: will they work? J. Clin. Invest. 94:1351. 1994.
5. Muzyczka, N., and K. I. Berns. Parvoviridae: the viruses and their replication. In: Fields virology, vol 2. D. M. Knipe, and P. M. Howley, eds. Lippincott Williams & Wilkins, Philadelphia. pp. 2327-2379. 2001.
6. Ni, Y. H. In vivo hepatic gene therapy. Acta Paediatr. Taiwan 42:191-200. 2001.
7. Pfeifer, A., and I. M. Verma. Gene therapy: promises and problems. Annu. Rev. Genomics Hum. Genet. 2:177-211. 2001.
8. Pieroni, L., C. Fipaldini, A. Monciotti, D. Cimini, A. Sgura, E. Fattori, O. Epifano, R. Cortese, F. Palombo, and N. La Monica. Targeted integration of adeno-associated virus-derived plasmids in transfected human cells. Virology 249:249-259. 1998.
9. Qiu, J., and D. J. Pintel. The adeno-associated virus type 2 Rep protein regulates RNA processing via interaction with the transcription template. Mol. Cell. Biol. 22:3639-3652. 2002.
10. Robbins, P. D., and S. C. Ghivizzani. Viral vectors for gene therapy. Pharmacol. Ther. 80:35-47. 1998.
11. Rohr, U. P., M. A. Wulf, S. Stahn, U. Steidl, R. Haas, and R. Kronenwett. Fast and reliable titration of recombinant adeno-associated virus type-2 using quantitative real-time PCR. J. Virol. Methods. 106:81-88. 2002.
12. Schwaab, R., and J. Oldenburg. Gene therapy of hemophilia. Semin. Thromb. Hemost. 27:417-424. 2001.
13. Silva, R. F. 2002. Recombinant vaccines and DNA Vaccines: Unfulfilled Promises. Poultry Vaccines and Vaccination Practices Symposium. 45th meeting of the American Association of Avian Pathologists, Nashville, Tennessee. pp. 32-45. 2002.
14. Smith-Arica, J. R., and J. S. Bartlett. Gene therapy: recombinant adeno-associated virus vectors. Curr. Cardiol. Rep. 3:43-49. 2001.
15. Steigerwald, R., C. Rabe, V. Schmitz, I. G. Schmidt-Wolf, M. Alt, and W. H. Caselmann. Requirements for adeno-associated virus-derived non-viral vectors to achieve stable and site-specific integration of plasmid DNA in liver carcinoma cells. Digestion 68:13-23. 2003.
16. Tsunoda, H., T. Hayakawa, N. Sakuragawa, and H. Koyama. Site-specific integration of adeno-associated virus-based plasmid vectors in lipofected HeLa cells. Virology 268:391-401. 2000.
17. Xiao, X., J. Li, and R. J. Samulski. Production of high-titer recombinant adeno-associated virus vectors in the absence of helper adenovirus. J. Virol. 72:2224-2232. 1998.
18. Xin, K. Q., T. Ooki, N. Jounai, H. Mizukami, K. Hamajima, Y. Kojima, K. Ohba, Y. Toda, S. Hirai, D. M. Klinman, K. Ozawa, and K. Okuda. A DNA vaccine containing inverted terminal repeats from adeno-associated virus increases immunity to HIV. J. Gene Med. 5:438-445. 2003.
19. Yang, C. C., X. Xiao, X. Zhu, D. C. Ansardi, N. D. Epstein, M. R. Frey, A. G. Matera, and R. J. Samulski. Cellular recombination pathways and viral terminal repeat hairpin structures are sufficient for adeno-associated virus integration in vivo and in vitro. J. Virol. 71:9231-9247. 1997.
20. Yates, V. J., A. M. el-Mishad, K. J. McCormick, and J. J. Trentin. Isolation and characterization of an avian adenovirus-associated virus. Infect. Immun. 7:973-980. 1973.